AI assistant
Sending…
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021
May 21, 2021
32782_dirs_2021-05-21_8ed64f03-364f-4436-bcb2-2770994e1b37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-05-19
Reporting Person: Patel Sanjiv (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-19 | Stock Option (Right to Buy) | $23.97 | A | 30000 | Acquired | 2031-05-19 | Ordinary Shares (30000) | Direct |
Footnotes
F1: The shares subject to the option will vest and become exercisable as to 33 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 1/3% on the second anniversary of the grant date, and the remaining 33 1/3% on the earlier of the third anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date.
More from PROTHENA CORP PUBLIC LTD CO
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Proxy Solicitation & Information Statement
2026
Mar 27
Transaction in Own Shares
2026
Feb 27
Annual Report
2026
Feb 27
Earnings Release
2026
Feb 19
Board/Management Information
2025
Dec 12
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 19
Major Shareholding Notification
2025
Nov 14
Major Shareholding Notification
2025
Nov 12
Major Shareholding Notification
2025
Nov 12